IL142012A0 - Stomach polypeptide zsig28 - Google Patents
Stomach polypeptide zsig28Info
- Publication number
- IL142012A0 IL142012A0 IL14201299A IL14201299A IL142012A0 IL 142012 A0 IL142012 A0 IL 142012A0 IL 14201299 A IL14201299 A IL 14201299A IL 14201299 A IL14201299 A IL 14201299A IL 142012 A0 IL142012 A0 IL 142012A0
- Authority
- IL
- Israel
- Prior art keywords
- zsig28
- stomach
- polypeptide
- stomach polypeptide
- polypeptide zsig28
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15444498A | 1998-09-16 | 1998-09-16 | |
PCT/US1999/021023 WO2000015659A2 (en) | 1998-09-16 | 1999-09-14 | Stomach polypeptide zsig28 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142012A0 true IL142012A0 (en) | 2002-03-10 |
Family
ID=22551383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14201299A IL142012A0 (en) | 1998-09-16 | 1999-09-14 | Stomach polypeptide zsig28 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1112364A2 (en) |
JP (1) | JP2002524103A (en) |
AU (1) | AU6143399A (en) |
CA (1) | CA2343001A1 (en) |
IL (1) | IL142012A0 (en) |
WO (1) | WO2000015659A2 (en) |
ZA (1) | ZA200101979B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030190669A1 (en) * | 1998-12-30 | 2003-10-09 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1251863A4 (en) * | 2000-01-31 | 2005-03-02 | Human Genome Sciences Inc | 22 human secreted proteins |
DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
AU2011256897B2 (en) * | 2004-05-18 | 2013-09-19 | Astellas Pharma Inc. | Genetic products differentially expressed in tumors and the use thereof |
DE102004024617A1 (en) * | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
SG11201503593UA (en) | 2012-11-13 | 2015-06-29 | Biontech Ag | Agents for treatment of claudin expressing cancer diseases |
WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
JP2023505318A (en) | 2019-12-06 | 2023-02-08 | ソティオ バイオテック エイ.エス. | Humanized CLDN18.2 antibody |
US20240034783A1 (en) | 2019-12-23 | 2024-02-01 | Sotio Biotech A.S. | Tumor-specific claudin 18.2 antibodies |
WO2022122709A1 (en) | 2020-12-07 | 2022-06-16 | Sotio Biotech A.S. | Antibody-drug conjugates based on humanized cldn18.2 antibodies |
JP2024500242A (en) | 2020-12-23 | 2024-01-05 | ソティオ バイオテック エイ.エス. | Complex of tumor-specific claudin 18.2 antibody and drug |
-
1999
- 1999-09-14 EP EP99948205A patent/EP1112364A2/en not_active Withdrawn
- 1999-09-14 CA CA002343001A patent/CA2343001A1/en not_active Abandoned
- 1999-09-14 WO PCT/US1999/021023 patent/WO2000015659A2/en not_active Application Discontinuation
- 1999-09-14 AU AU61433/99A patent/AU6143399A/en not_active Abandoned
- 1999-09-14 IL IL14201299A patent/IL142012A0/en unknown
- 1999-09-14 JP JP2000570197A patent/JP2002524103A/en active Pending
-
2001
- 2001-03-09 ZA ZA200101979A patent/ZA200101979B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU6143399A (en) | 2000-04-03 |
WO2000015659A3 (en) | 2000-06-08 |
ZA200101979B (en) | 2001-10-02 |
WO2000015659A2 (en) | 2000-03-23 |
JP2002524103A (en) | 2002-08-06 |
EP1112364A2 (en) | 2001-07-04 |
CA2343001A1 (en) | 2000-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL344341A1 (en) | Peptides | |
EP1142992A4 (en) | Polypeptides | |
IL142012A0 (en) | Stomach polypeptide zsig28 | |
HK1039158A1 (en) | Nlk1-interacting proteins | |
GB0127675D0 (en) | Polypeptide | |
GB9825854D0 (en) | Peptide | |
EP1103604A4 (en) | Novel polypeptide | |
GB9815505D0 (en) | Polypeptide derivatives | |
EP1197556A4 (en) | Useful polypeptide | |
PL344979A1 (en) | Angiostatin-binding protein | |
GB9812675D0 (en) | Peptides | |
GB9828704D0 (en) | Proteins | |
GB9816337D0 (en) | Proteins | |
GB9828880D0 (en) | Protein | |
GB9807890D0 (en) | Peptides | |
HK1045173A1 (en) | Polypeptide | |
GB0224538D0 (en) | Polypeptide | |
HUP9900288A3 (en) | Overlapping connection | |
GB9819387D0 (en) | Polypeptide | |
GB9812607D0 (en) | Protein | |
GB9809566D0 (en) | Protein | |
GB9819038D0 (en) | Protein | |
GB9918680D0 (en) | Polypeptide | |
IL140120A0 (en) | Immunomodulator polypeptide zsig57 | |
GB9816336D0 (en) | Proteins |